Cancer Immunology, Immunotherapy

, Volume 55, Issue 7, pp 808–818 | Cite as

Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes

  • Monika Baj-Krzyworzeka
  • Rafał Szatanek
  • Kazimierz Węglarczyk
  • Jarosław Baran
  • Barbara Urbanowicz
  • Piotr Brański
  • Mariusz Z. Ratajczak
  • Marek ZembalaEmail author
Original Article


This study was designed to determine the characteristics of tumour cell-derived microvesicles (TMV) and their interactions with human monocytes. TMV were shed spontaneously by three different human cancer cell lines but their release was significantly increased upon activation of the cells with phorbol 12-myristate 13-acetate (PMA). TMV showed the presence of several surface determinants of tumour cells, e.g. HLA class I, CD29, CD44v7/8, CD51, chemokine receptors (CCR6, CX3CR1), extracellular matrix metalloproteinase inducer (EMMPRIN), epithelial cell adhesion molecule (EpCAM), but their level of expression differed from that on cells they originated from. TMV also carried mRNA for growth factors: vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), interleukin-8 (IL-8) and surface determinants (CD44H). TMV were localized at the monocytes surface following their short exposure to TMV, while at later times intracellularly. TMV transferred CCR6 and CD44v7/8 to monocytes, exerted antiapoptotic effect on monocytes and activated AKT kinase (Protein Kinase B). Thus, TMV interact with monocytes, alter their immunophenotype and biological activity. This implicates the novel mechanism by which tumour infiltrating macrophages may be affected by tumour cells not only by a direct cell to cell contact, soluble factors but also by TMV.


Tumour-derived microvesicles Monocytes Transfer CCR6 mRNA 



This study was supported by the State Committee for Scientific Research (grant no. 3P05A 057 22 and PBZ-KBN-091/P05/2003). We thank Ms B. Hajto, I.Ruggiero and M. Wołoszyn for skillful technical assistance.


  1. 1.
    Albanese J, Meterissian S, Kontogiannea M, Dubreuil C, Hand A, Sorba S, Dainiak N (1998) Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles. Blood 91:3862–3874PubMedGoogle Scholar
  2. 2.
    Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, Squarcina P, Accornero P, Lozupone F, Lugini L, Stringaro A, Molinari A, Arancia G, Gentile M, Parmiani G, Fais S (2002) Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 195:1303–1316CrossRefPubMedGoogle Scholar
  3. 3.
    Bachelder RE, Wendt MA, Fujita N, Tsuruo T, Mercurio AM (2001) The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment induced apoptosis. J Biol Chem 276:34702–34707CrossRefPubMedGoogle Scholar
  4. 4.
    Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J, Reca R, Janowska-Wieczorek A, Ratajczak MZ (2002) Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30:450–459CrossRefPubMedGoogle Scholar
  5. 5.
    Baran J, Weglarczyk K, Mysiak M, Guzik K, Ernst M, Flad HD, Pryjma J (2001) Fas (CD95)-Fas ligand interactions are responsible for monocyte apoptosis occurring as a result of phagocytosis and killing of Staphylococcus aureus. Infect Immun 69:1287–1297CrossRefPubMedGoogle Scholar
  6. 6.
    Barz D, Goppelt M, Szamel M, Schirrmacher V, Resch K (1985) Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant (ESb). Biochim Biophys Acta 814:77–84PubMedCrossRefGoogle Scholar
  7. 7.
    Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231–241CrossRefPubMedGoogle Scholar
  8. 8.
    Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13:2905–1927CrossRefPubMedGoogle Scholar
  9. 9.
    Dolo V, Adobati E, Canevari S, Picone MA, Vittorelli ML (1995) Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis 13:277–286CrossRefPubMedGoogle Scholar
  10. 10.
    Dolo V, Ginestra A, Cassara D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A, Vittorelli ML (1998) Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 58:4468–4474PubMedGoogle Scholar
  11. 11.
    Forlow SB, McEver RP, Nollert MU (2000) Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 95:1317–1323PubMedGoogle Scholar
  12. 12.
    Friedl P, Maaser K, Klein CE, Niggemann B, Krohne G, Zanker KS (1997) Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matric reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res 57:2061–2070PubMedGoogle Scholar
  13. 13.
    Fritzsching B, Schwer B, Kartenbeck J, Pedal A, Horejsi V, Ott M (2002) Release and intercellular transfer of cell surface CD81 via microparticles. J Immunol 169:5531–5537PubMedGoogle Scholar
  14. 14.
    Fujimi S, Ogura H, Tanaka H, Koh T, Hosotsubo H, Nakamori Y, Kuwagata Y, Shimazu T, Sugimoto H (2002) Activated polymorphonuclear leukocytes enhance production of leukocyte micropraticles with increased adhesion molecules in patients with sepsis. J Trauma 52:443–448PubMedCrossRefGoogle Scholar
  15. 15.
    George JN, Thoi LL, McManus LM, Reimann TA (1982) Isolation of human platelet membrane microparticles from plasma and serum. Blood 60: 834–840PubMedGoogle Scholar
  16. 16.
    Horstman LL, Jy W, Jimenez JJ, Ahn YS (2004) Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9:1118–1135PubMedCrossRefGoogle Scholar
  17. 18.
    Kim CW, Lee HM, Lee TH, Kang C, Kleinman HK, Gho YS (2002) Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 62:6312–6317PubMedGoogle Scholar
  18. 19.
    Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Kim HK, Ryu KW, Bae JM, Kim S (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39:184–191CrossRefPubMedGoogle Scholar
  19. 20.
    Levesque MC, Haynes BF (1996) In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol 156:1557–1565PubMedGoogle Scholar
  20. 21.
    Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265–270CrossRefPubMedGoogle Scholar
  21. 22.
    Marhaba R, Bourouba M, Zoller M (2003) CD44v7 interferes with activation – induced cell death by up-regulation of anti apoptotic gene expression. J Leukoc Biol 74:135–148CrossRefPubMedGoogle Scholar
  22. 23.
    Mayer C, Maaser K, Daryab N, Zanker KS, Brocker EB, Friedl P (2004) Release of cell fragments by invading melanoma cells. Eur J Cell Biol 83:709–715CrossRefPubMedGoogle Scholar
  23. 24.
    Mesri M, Altieri DC (1998) Endothelial cell activation by leukocyte microparticles. J Immunol 161:4382–4387PubMedGoogle Scholar
  24. 25.
    Mytar B, Siedlar M, Woloszyn M, Collizzi V, Zembala M (2001) Cross-talk between human monocytes and cancer cells during reactive oxygen intermediates generation the essential role of hyaluronan. Int J Cancer 94:727–732CrossRefPubMedGoogle Scholar
  25. 26.
    Mytar B, Baran J, Gawlicka M, Ruggiero I, Zembala M (2002) Immunophenotypic changes and induction of apoptosis of monocytes and tumour cells during their interactions in vitro. Anticaner Res 22:2789–2796Google Scholar
  26. 27.
    Mytar B, Woloszyn M, Szatanek R, Baj-Krzyworzeka M, Siedlar M Ruggiero I, Wieckiewicz J, Zembala M (2003) Tumor cell-induced deactivation of human monocytes. J Leukoc Biol 74:1094–1101CrossRefPubMedGoogle Scholar
  27. 28.
    Omoto S, Nomura S, Shouzu a, Nishikawa M, Fukuhara S, Iwasaka T (2002) Detection of monocyte-derived macroparticles in patients with Type II diabetes mellitus. Diabetologia 45:550–555CrossRefPubMedGoogle Scholar
  28. 29.
    Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78CrossRefPubMedGoogle Scholar
  29. 30.
    Reddy SM, Hsiao KH, Abernethy VE, Fan H, Longacre A, Lieberthal W, Rauch J, Koh JS, Levine JS (2002) Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2. J Immunol 169:702–713PubMedGoogle Scholar
  30. 31.
    Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J, Dignat-George F (2002) Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99: 3962–3970CrossRefPubMedGoogle Scholar
  31. 32.
    Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, Hedman H, Freyssinet JM (1994) Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 153:3245–3255PubMedGoogle Scholar
  32. 33.
    Scholz T, Temmler U, Krause S, Heptinstall S, Losche W (2002) Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thromb Haemost 66:1033–1038Google Scholar
  33. 34.
    Seiter S, Schmidt DS, Zoller M (2000) The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities. Int Immunol 12:37–49CrossRefPubMedGoogle Scholar
  34. 35.
    Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR (2003) Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 63:4331–4337PubMedGoogle Scholar
  35. 36.
    Sidhu SS, Mengistab AT, Tauscher AN, LaVail J, Basbaum C (2004) The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 29:956–963CrossRefGoogle Scholar
  36. 37.
    Taylor DD, Gercel-Taylor C (2005) Tumour-derived exosomes and their role in cancer-associated T-cell signaling defects. Br J Cancer 92:305–311PubMedGoogle Scholar
  37. 38.
    Van Amersfoort ES, Van Strijp JA (1994) Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 17:294–301CrossRefPubMedGoogle Scholar
  38. 39.
    Wang HQ, Quan T, He T, Franke TF, Voorhees JJ, Fisher GJ (2003) Epidermal growth factor receptor dependent, NFkB independent activation of the phosphatidyloinositol 3 kinase/Akt pathway inhibits ultraviolet irradiation induced caspase −3, −8, and 9 in human keratinocytes. J Biol Chem 278: 45737–45745CrossRefPubMedGoogle Scholar
  39. 40.
    Weiss JM, Renkl AC, Ahrens T, Moll J, Mai BH, Denfeld RW, Schopf E, Ponta H, Herrlich P, Simon JC (1998) Activation-dependent modulation of hyaluronate-receptor expression and of hyaluronate-avidity by human monocytes. J Invest Dermatol 111:227–232CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Monika Baj-Krzyworzeka
    • 1
  • Rafał Szatanek
    • 1
  • Kazimierz Węglarczyk
    • 1
  • Jarosław Baran
    • 1
  • Barbara Urbanowicz
    • 3
  • Piotr Brański
    • 4
  • Mariusz Z. Ratajczak
    • 2
  • Marek Zembala
    • 1
    Email author
  1. 1.Department of Clinical ImmunologyPolish-American Institute of Paediatrics, Jagiellonian University Medical CollegeCracowPoland
  2. 2.Department of TransplantologyPolish-American Institute of Paediatrics, Jagiellonian University Medical CollegeCracowPoland
  3. 3.Department of PathologyPolish-American Institute of Paediatrics, Jagiellonian University Medical CollegeCracowPoland
  4. 4.Department of Neurobiology, Institute of PharmacologyPolish Academy of ScienceCracowPoland

Personalised recommendations